PVT1 dependence in cancer with MYC copy-number increase

Nature

Volumn 512, Issue 1, 2014, Pages 82-86

  Tseng, Yuen Yi ^a   Moriarity, Branden S ^b   Gong, Wuming ^a,b   Akiyama, Ryutaro ^a,c   Tiwari, Ashutosh ^b,d   Kawakami, Hiroko ^a,c   Ronning, Peter ^a   Reuland, Brian ^a   Guenther, Kacey ^a   Beadnell, Thomas C ^c   Essig, Jaclyn ^a   Otto, George M ^b   O'Sullivan, M Gerard ^b   Largaespada, David A ^a,b   Schwertfeger, Kathryn L ^b,c   Marahrens, York ^a   Kawakami, Yasuhiko ^a,c   Bagchi, Anindya ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^d Translational Health Science and Technology Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOMES, HUMAN, PAIR 8; DISEASE MODELS, ANIMAL; DNA COPY NUMBER VARIATIONS; GENE AMPLIFICATION; GENE DOSAGE; GENES, MYC; HCT116 CELLS; HUMANS; MICE; MICE, INBRED C57BL; ONCOGENE PROTEIN P55(V-MYC); PHENOTYPE; RNA, LONG NONCODING;

EID: 84905578200     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature13311     Document Type: Article

References (37)

1. Huppi, K., Pitt, J. J., Wahlberg, B. M. & Caplen, N. J. The 8q24 gene desert: an oasis of non-coding transcriptional activity. Front. Genet. 3, 69 (2012).
2. Haverty, P. M., Hon, L. S., Kaminker, J. S., Chant, J. & Zhang, Z. High-resolution analysisofcopy number alterationsand associated expressionchangesinovarian tumors. BMC Med. Genomics 2, 21 (2009).
3. Guan, Y. et al. Amplification of PVT1 contributes to the pathophysiology of ovarian and breast cancer. Clin. Cancer Res. 13, 5745-5755 (2007).
4. van Duin, M. et al. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas. Cytogenet. Genome Res. 118, 130-137 (2007).
5. Borg, A., Baldetorp, B., Ferno, M., Olsson, H. & Sigurdsson, H. c-myc amplification is an independent prognostic factor in postmenopausal breast cancer. Int. J. Cancer 51, 687-691 (1992).
6. Kim, Y. H. et al. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Oncogene 25, 130-138 (2006).
7. Sato, K. et al. Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma. J. Natl Cancer Inst. 91, 1574-1580 (1999).
8. Lapointe, J. et al. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis. Cancer Res. 67, 8504-8510 (2007).
9. Douglas, E. J. et al. Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res. 64, 4817-4825 (2004).
10. Zitterbart, K. et al. Low-levelcopy numberchangesofMYC genes haveaprognostic impact in medulloblastoma. J. Neurooncol. 102, 25-33 (2011).
11. Yamada, T. et al. Frequent chromosome 8q gains in human small cell lung carcinoma detected by arbitrarily primed-PCR genomic fingerprinting. Cancer Genet. Cytogenet. 120, 11-17 (2000).
12. Le Beau, M. M., Bitts, S., Davis, E. M. & Kogan, S. C. Recurring chromosomal abnormalities in leukemia in PML-RARA transgenic mice parallel human acute promyelocytic leukemia. Blood 99, 2985-2991 (2002).
13. Chin, K. et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10, 529-541 (2006).
14. Jain, A. N. et al. Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival. Proc. Natl Acad. Sci. USA 98, 7952-7957 (2001).
15. Ramirez-Solis, R., Liu, P. & Bradley, A. Chromosome engineering in mice. Nature 378, 720-724 (1995).
16. Al-Kuraya, K. et al. Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res. 64, 8534-8540 (2004).
17. Park, K., Kwak, K., Kim, J., Lim, S. & Han, S. c-myc amplification is associated with HER2 amplification and closely linked with cell proliferation in tissue microarray of nonselected breast cancers. Hum. Pathol. 36, 634-639 (2005).
18. Guy, C. T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl Acad. Sci. USA 89, 10578-10582 (1992).
19. Saji, S. et al. Estrogen receptors a and b in the rodent mammary gland. Proc. Natl Acad. Sci. USA 97, 337-342 (2000).
20. Carramusa, L. et al. The PVT-1 oncogene is a Myc protein target that is overexpressed in transformed cells. J. Cell. Physiol. 213, 511-518 (2007).
21. Lin, M. et al. RNA-Seq of human neurons derived from iPS cells reveals candidate long non-coding RNAs involved in neurogenesis and neuropsychiatric disorders. PLoS ONE 6, e23356 (2011).
22. Zhang, X. et al. Mechanistic insight into Myc stabilization in breast cancer involving aberrant Axin1 expression. Proc. Natl Acad. Sci. USA 109, 2790-2795 (2012).
23. Yeh, E. et al. A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nature Cell Biol. 6, 308-318 (2004).
24. Wang, X. et al. Phosphorylation regulates c-Myc's oncogenic activity in the mammary gland. Cancer Res. 71, 925-936 (2011).
25. Morin, P. J. et al. Activation of b-catenin-Tcf signaling in colon cancer by mutations in b-catenin or APC. Science 275, 1787-1790 (1997).
26. Delmore, J. E. et al. BET bromodomain inhibition as a therapeutic strategyto target c-Myc. Cell 146, 904-917 (2011).
27. Darnell, J. E., Jr. Transcription factors as targets for cancer therapy. Nature Rev. Cancer 2, 740-749 (2002).
28. Nair, S. K. & Burley, S. K. X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 112, 193-205 (2003).
29. Bagchi, A. et al. CHD5 is a tumor suppressor at human 1p36. Cell 128, 459-475 (2007).
30. Schwertfeger, K. L. et al. A critical role for the inflammatory response in a mouse model of preneoplastic progression. Cancer Res. 66, 5676-5685 (2006).
31. Reed, J. R. et al. Fibroblast growthfactor receptor1activationinmammarytumor cells promotes macrophage recruitmentin aCX3CL1-dependent manner. PLoS ONE 7, e45877 (2012).
32. Lee, G. Y., Kenny, P. A., Lee, E. H. & Bissell, M. J. Three-dimensional culture models of normal and malignant breast epithelial cells. Nature Methods 4, 359-365 (2007).
33. Kenny, P. A. et al. The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profilesofgene expression. Mol. Oncol. 1, 84-96 (2007).
34. Itou, J. et al. Migration of cardiomyocytes is essential for heart regeneration in zebrafish. Development 139, 4133-4142 (2012).
35. Keene, J. D., Komisarow, J. M. & Friedersdorf, M. B. RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nature Protocols 1, 302-307 (2006).
36. Moriarity, B. S. et al. Simple and efficient methods for enrichment and isolation of endonuclease modified cells. PloS One 9, e96114 (2014).
37. Rahrmann, E. P. et al. Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nature Genet. 45, 756-766 (2013).